264 related articles for article (PubMed ID: 29030718)
21. Lacosamide monotherapy for partial onset seizures.
Lattanzi S; Cagnetti C; Foschi N; Provinciali L; Silvestrini M
Seizure; 2015 Apr; 27():71-4. PubMed ID: 25891931
[TBL] [Abstract][Full Text] [Related]
22. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
[TBL] [Abstract][Full Text] [Related]
23. Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas.
Sherman JH; Moldovan K; Yeoh HK; Starke RM; Pouratian N; Shaffrey ME; Schiff D
J Neurosurg; 2011 Jun; 114(6):1617-21. PubMed ID: 21235313
[TBL] [Abstract][Full Text] [Related]
24. Adjunctive lacosamide--5 years' clinical experience.
Stephen LJ; Kelly K; Parker P; Brodie MJ
Epilepsy Res; 2014 Oct; 108(8):1385-91. PubMed ID: 25064538
[TBL] [Abstract][Full Text] [Related]
25. Outcome of cancer-related seizures in patients treated with lacosamide.
Toledo M; Molins A; Quintana M; Santamarina E; Martinez-Ricarte F; Martínez-Saez E; Salas-Puig J
Acta Neurol Scand; 2018 Jan; 137(1):67-75. PubMed ID: 28832891
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy.
Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P
Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195
[TBL] [Abstract][Full Text] [Related]
27. Lacosamide: A Review in Focal-Onset Seizures in Patients with Epilepsy.
Hoy SM
CNS Drugs; 2018 May; 32(5):473-484. PubMed ID: 29785508
[TBL] [Abstract][Full Text] [Related]
28. Effect of lacosamide on depression and anxiety symptoms in patients with focal refractory epilepsy: A prospective multicenter study.
Rocamora R; Ley M; Molins A; Toledo M; Sansa G; Bertol V; Becerra JL; Carreño M; Mauri JÁ
Epilepsy Behav; 2018 Feb; 79():87-92. PubMed ID: 29253680
[TBL] [Abstract][Full Text] [Related]
29. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T;
Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and tolerability of lacosamide as adjunctive therapy in patients with focal-onset seizures: an observational, prospective study.
Jin Y; Zhang R; Jiang J; Liu X
Acta Neurol Belg; 2023 Jun; 123(3):1081-1087. PubMed ID: 37004703
[TBL] [Abstract][Full Text] [Related]
31. Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study.
Koekkoek JA; Kerkhof M; Dirven L; Heimans JJ; Postma TJ; Vos MJ; Bromberg JE; van den Bent MJ; Reijneveld JC; Taphoorn MJ
BMC Neurol; 2014 Aug; 14():157. PubMed ID: 25124385
[TBL] [Abstract][Full Text] [Related]
32. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial.
Chung S; Sperling MR; Biton V; Krauss G; Hebert D; Rudd GD; Doty P;
Epilepsia; 2010 Jun; 51(6):958-67. PubMed ID: 20132285
[TBL] [Abstract][Full Text] [Related]
33. Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability.
Maschio M; Dinapoli L; Mingoia M; Sperati F; Pace A; Pompili A; Carapella CM; Vidiri A; Muti P
J Neurol; 2011 Nov; 258(11):2100-4. PubMed ID: 21674196
[TBL] [Abstract][Full Text] [Related]
34. A retrospective two-center study of antiepileptic prophylaxis in patients with surgically treated high-grade gliomas.
Garbossa D; Panciani PP; Angeleri R; Battaglia L; Tartara F; Ajello M; Agnoletti A; Versari P; Ducati A; Fontanella M; Spena G
Neurol India; 2013; 61(2):131-7. PubMed ID: 23644311
[TBL] [Abstract][Full Text] [Related]
35. Seizure response to perampanel in drug-resistant epilepsy with gliomas: early observations.
Vecht C; Duran-Peña A; Houillier C; Durand T; Capelle L; Huberfeld G
J Neurooncol; 2017 Jul; 133(3):603-607. PubMed ID: 28492978
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of lacosamide by focal seizure subtype.
Sperling MR; Rosenow F; Faught E; Hebert D; Doty P; Isojärvi J
Epilepsy Res; 2014 Oct; 108(8):1392-8. PubMed ID: 25082395
[TBL] [Abstract][Full Text] [Related]
37. Lacosamide efficacy and tolerability in clinical practice - Post marketing analysis from a single dedicated epilepsy center.
Baker MD; Abou-Khalil BW; Arain A; Tummala P; Azar NJ; Haas KF; Sonmezturk HH
Clin Neurol Neurosurg; 2018 Aug; 171():179-183. PubMed ID: 29929174
[TBL] [Abstract][Full Text] [Related]
38. Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide.
Villanueva V; López FJ; Serratosa JM; González-Giraldez B; Campos D; Molins A; Rodriguez Uranga J; Mauri JA; Salas-Puig J; Toledo M; Sánchez-Alvarez JC; Moreno A; Serrano-Castro PJ; Saiz-Diaz RA; González de la Aleja J; de la Peña P; Asensio M
Epilepsy Behav; 2013 Nov; 29(2):349-56. PubMed ID: 23999191
[TBL] [Abstract][Full Text] [Related]
39. A case series of lacosamide as adjunctive therapy in refractory sleep-related hypermotor epilepsy (previously nocturnal frontal lobe epilepsy).
Samarasekera SR; Berkovic SF; Scheffer IE
J Sleep Res; 2018 Oct; 27(5):e12669. PubMed ID: 29479765
[TBL] [Abstract][Full Text] [Related]
40. Lacosamide tolerability in adult patients with partial-onset seizures: Impact of planned reduction and mechanism of action of concomitant antiepileptic drugs.
Foldvary-Schaefer N; Fong JS; Morrison S; Wang L; Bena J
Epilepsy Behav; 2016 Apr; 57(Pt A):155-160. PubMed ID: 26956629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
